Redefining Tuberculous Meningitis Diagnostics with Metagenomic Next Generation Sequencing |
Prashanth Ramachandran, MBBS |
Tuberculosis, Drug and Diagnostics Development |
|
|
Tackling Tuberculous Meningitis on the Ground: Bringing Advanced Diagnostics to Uganda |
Prashanth Ramachandrani, MBBS |
Tuberculosis, Drug and Diagnostics Development, Neurology and Mental Health, Training International Scholars and Clinicians |
|
|
Engagement and retention in tuberculosis care services among people living with HIV in Lusaka, Zambia: does gender matter? |
Andrew Kerkhoff, MD, PhD |
HIV/AIDS, Tuberculosis, Stigma and Discrimination, Engagement in Care, Treatment Adherence |
|
|
Role of Antigen-Specific T Cell Responses in the Control of TB |
Joel D. Ernst, MD |
Tuberculosis, Immunology |
|
|
Antigen export in M. tuberculosis evasion of CD4 T cells |
Joel D. Ernst, MD |
Tuberculosis, Immunology |
|
|
Cellular and Bacterial Dynamics in Tuberculosis |
Joel D. Ernst, MD |
Tuberculosis, Immunology |
|
|
Improving urine-based tuberculosis diagnosis in people living with HIV |
Devan Jaganath, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Exhaled Breath Biomarkers for the Diagnosis of TB in Children |
Devan Jaganath, MD |
Tuberculosis, Drug and Diagnostics Development, Pediatrics |
|
|
Exhaled Breath Biomarkers for the Diagnosis of TB in Children |
Devan Jaganath, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Building Evidence for Advancing New Treatment For XDR/XDR-TB (BEAT TUBERCULOSIS) Study |
Patrick Phillips, PhD, MS, MA |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Pharmacology and Drug Treatment |
|
|
Modernization of Phase 3 TB Clinical Trial Endpoints |
Patrick Phillips, PhD, MS, MA |
Tuberculosis, Pharmacology and Drug Treatment, Systematic Reviews and Guideline Development |
|
|
Clinical trials to improve the treatment of drug-sensitive and MDR-TB |
Patrick Phillips, PhD, MS, MA |
Tuberculosis, Immunology, Pharmacology and Drug Treatment |
|
|
Expand New Drug Markets for TB (endTB) |
Patrick Phillips, PhD, MS, MA |
Tuberculosis, Epidemiology and Surveillance |
|
|
PanACEA |
Patrick Phillips, PhD, MS, MA |
Tuberculosis, Epidemiology and Surveillance |
|
|
The Yield of Tuberculosis Contact Investigation in Low-Resource, High-Burden Settings: A Systematic Review and Meta-Analysis |
Mariana Velleca, MS |
Tuberculosis, Systematic Reviews and Guideline Development, Epidemiology and Surveillance |
|
|
Controlling Tuberculosis: A Cost-Effectiveness Analysis of the Drone Observed Therapy System as an Alternative Diagnostic and Treatment Method in Nepal |
Brittney Butler, MS |
Tuberculosis, Health Economics and Effectiveness |
|
|
Assessing the Acceptability and Feasibility of Using a Video-Based Education Curriculum for Tuberculosis Prevention and Control in Pyuthan District, Nepal |
Shrishti Bhattarai, MS |
Tuberculosis, Patient and Peer Education |
|
|
Health Education Videos for Tuberculosis Management in Remote Madagascar |
Hailey Reeves, MS |
Tuberculosis, Patient and Peer Education |
|
|
Drug-Resistant Tuberculosis on the Texas-Mexico Border: Improving the Quality of bi-national TB Projects |
Camila Hurtado, MS |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis |
|
|
Tuberculosis guidelines and best practices internationally |
Sarah Royce, MD, MPH |
Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Tuberculosis |
|
|
Evaluation of Point-of-Care C-reactive Protein Assay as a Serial Screening Tool for Active Tuberculosis among People Living with HIV in Uganda |
Paul Park, MS |
Tuberculosis |
|
|
From Poverty to Cure: Overcoming Socioeconomic Barriers to Tuberculosis Care |
Priya Shete, MD |
Tuberculosis, Implementation and Behavioral Science |
|
|
Overcoming socioeconomic barriers to TB care: the case for social protection |
Priya Shete, MD |
Tuberculosis, Engagement in Care, Treatment Adherence |
|
|
Evaluating the Impact of Cash Transfers on Tuberculosis (TB) Care: ExaCT TB Study |
Priya Shete, MD |
Tuberculosis, Health Economics and Effectiveness, Implementation and Behavioral Science |
|
|
Targeted Behavioral Incentives for Improving Tuberculosis (TB) Diagnostic Evaluation Outcomes |
Priya Shete, MD |
HIV/AIDS, Tuberculosis |
|
|
Diabetes and Tuberculosis in Brazilian slum settings |
Jayant Rajan, MD |
Tuberculosis, Noncommunicable and/or Chronic Disease, Diabetes, Occupational and Environmental Disease, Access or Barriers to Care, Stigma and Discrimination |
|
|
Improving care delivery for people living with HIV, TB and other chronic diseases through diplomacy |
Michael J. Reid, MD |
Infectious Disease, Sexually Transmitted Infections (STIs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Policy and Standards of Care, Systematic Reviews and Guideline Development, Health Systems Strengthening |
|
|
Regional Training and Medical Consultation Center |
Lisa Chen, MD |
Tuberculosis |
|
|
Continuing Education for Health Professionals for tuberculosis patient care |
Lisa Chen, MD |
Tuberculosis, Residencies, Fellowships, and Postdoctoral Training |
|
|
Continuing Education for the Curry Center |
Lisa Chen, MD |
Tuberculosis |
|
|
Regional Training and Medical Consultation Center |
Lisa Chen, MD |
Tuberculosis |
|
|
Operations Research Training Curriculum for Tuberculosis Control |
Lisa Chen, MD |
Tuberculosis |
|
|
TB Free California |
Shereen Katrak, MD MPH |
Tuberculosis, Stigma and Discrimination, Epidemiology and Surveillance |
|
|
Childhood Tuberculosis Infection Among School-Age Children in Rural Uganda |
Carina Marquez, MD |
Tuberculosis, Pediatrics |
|
|
Childhood Tuberculosis Infection Among School-Age Children in Rural Uganda |
Carina Marquez, MD |
HIV/AIDS, Tuberculosis, Pediatrics, Epidemiology and Surveillance |
|
|
Surveilling the syndemic: Assessment of an integrated tuberculosis and HIV pilot surveillance system in Haiti |
Kristiana Dhillon, MS |
HIV/AIDS, Tuberculosis |
|
|
Exploring the role of a novel, polymorphic protein family in M. tuberculosis pathogenesis |
|
Tuberculosis, Immunology |
|
|
UN Special Envoy for Tuberculosis: Strategic Priorities |
Eric Goosby, MD |
Tuberculosis, Health Economics and Effectiveness, Policy and Standards of Care |
|
|
Office of the UN Special Envoy for Tuberculosis |
Eric Goosby, MD |
Tuberculosis, Policy and Standards of Care |
|
|
Intergovernmental Personnel Agreement (IPA) |
Eric Goosby, MD |
HIV/AIDS, Tuberculosis |
|
|
First Lancet Commission Meeting 11-13 July 2017, San Francisco, California |
Eric Goosby, MD |
Tuberculosis, Policy and Standards of Care |
|
|
Point-of-care C-reactive protein-based tuberculosis screening in people living with HIV: a randomized trial |
Christina Yoon, MD, MPH |
Tuberculosis |
|
|
Point-of-care C-reactive protein-based tuberculosis screening among people living with HIV: planning a comparative effectiveness trial |
Christina Yoon, MD, MPH |
HIV/AIDS, Tuberculosis |
|
|
Combining 3HP with active case finding to maximize the impact of mass TB screening campaign in the Marshall Islands |
Christina Yoon, MD, MPH |
Tuberculosis, Diabetes, Epidemiology and Surveillance, Engagement in Care |
|
|
Improving the efficiency of clinic-based active tuberculosis case finding: point-of-care C-reactive protein-based TB triage testing in Vietnam |
Christina Yoon, MD, MPH |
Tuberculosis, Drug and Diagnostics Development |
|
|
Evaluation of Novel Tuberculosis Screening Strategies for People living with HIV |
Christina Yoon, MD, MPH |
HIV/AIDS, Tuberculosis |
|
|
Protein secretion in bacterial pathogens |
Oren Rosenberg, MD, PhD |
Tuberculosis |
|
|
Structural and functional studies of M. tuberculosis type VII secretion |
Oren Rosenberg, MD, PhD |
Tuberculosis |
|
|
UCSF-GIVI CFAR East Africa Regional Director |
|
HIV/AIDS, Tuberculosis, Malaria, Training and Capacity Building, Training International Scholars and Clinicians |
|
|
Pharmacokinetics and tolerability of adjunctive linezolid for the treatment of tuberculous meningitis |
Felicia Chow, MD |
HIV/AIDS, Tuberculosis, Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Redefining Tuberculosis Meningitis with Metagenomics and Host Transciptomics |
Michael Wilson, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Making Better Decisions: Policy Modeling for AIDS and Drug Abuse |
James Kahn, MD, MPH |
HIV/AIDS, Tuberculosis, Health Economics and Effectiveness |
|
|
Commission on Investing in Health (CIH) Phase 3: Leveraging Global Health 2035 to Shape the SDGs and the Health Investments of Donor, Low-Income and Middle-Income Countries |
|
Tuberculosis, Malaria, Women's Health, Policy and Standards of Care, Systematic Reviews and Guideline Development |
|
|
Lesion-centric imaging and PK-PD of pyrazinamide for TB/HIV co-infection |
Rada Savic, PhD |
Tuberculosis |
|
|
Identifying Optimal Treatment Strategies for Tuberculosis Treatment |
Rada Savic, PhD |
Tuberculosis, Pharmacology and Drug Treatment |
|
|
Multiscale System Pharmacology Disease Platform for Tuberculosis |
Rada Savic, PhD |
Tuberculosis |
|
|
Lesion Drug Penetration and Translational Modeling |
Rada Savic, PhD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Adherence Monitoring impact in Global Health - Planning Grant |
Rada Savic, PhD |
Tuberculosis, Treatment Adherence |
|
|
Nonlinear Mixed Effects Modeling of Rifapentine in Children |
Rada Savic, PhD |
Tuberculosis, Pediatrics |
|
|
Nonlinear Mixed Effects Modeling of Rifapentine Pharmacokinetics |
Rada Savic, PhD |
Tuberculosis, Pharmacology and Drug Treatment |
|
|
De Facto Monotherapy during Multidrug Tuberculosis Treatment and Emergence of Resistance |
Rada Savic, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis |
|
|
Optimal MDR treatment in children |
Rada Savic, PhD |
Tuberculosis, Pediatrics |
|
|
Integrative Pharmacology Approach to Understand Mechanisms of Tuberculosis Drug Resistance |
Rada Savic, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development |
|
|
Biostatistical analysis of Mycobacterium Tuberculosis Biomarkers for Diagnosis and Cure |
Rada Savic, PhD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Mechanism-Based Integrative Pharmacology Model for Tuberculosis |
Rada Savic, PhD |
Tuberculosis, Pharmacology and Drug Treatment |
|
|
Optimal MDR treatment in children |
Rada Savic, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis |
|
|
Novel Biomarkers to Shorten TB Treatment |
Rada Savic, PhD |
Tuberculosis |
|
|
Impact of Pregnancy on Tuberculosis |
Rada Savic, PhD |
Tuberculosis, Pharmacology and Drug Treatment, Women's Health, Labor and Delivery, Newborn and Infant Health |
|
|
Impact of Pregnancy on Tuberculosis |
Rada Savic, PhD |
Tuberculosis, Women's Health, Labor and Delivery, Newborn and Infant Health |
|
|
Oxygen Sensors and P450 Monooxygenases in Mycobacertium tuberculosis |
|
Tuberculosis, Immunology |
|
|
Oxygen Sensors and P450 Monooxgenases in Mycobacterium tuberculosis |
|
Tuberculosis |
|
|
WHO Cochrane: Programmatic Management of Drug Resistant Tuberculosis (PMDT) |
|
Tuberculosis |
|
|
Effects of Air Pollution on Childhood Tuberculosis in Viet Nam |
|
Tuberculosis, Pediatrics |
|
|
Novel Techniques for the Detections of Pediatric Tuberculosis in Ethiopia |
Caryn Bern, MD, MPH |
Tuberculosis, Pediatrics |
|
|
UCSF-GIVI Center for AIDS Research (CFAR) |
Paul Volberding, MD |
HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Drug and Diagnostics Development, Immunology, Pharmacology and Drug Treatment, Neurology and Mental Health, Trauma and PTSD, Women's Health, Pediatrics, Implementation and Behavioral Science, Training and Capacity Building, Training International Scholars and Clinicians |
|
|
DOT (Directly observed therapy) Diary |
Eric Vittinghoff, PhD |
HIV/AIDS, Tuberculosis |
|
|
International Clinical Research Fellowship |
Christopher Stewart, MD |
Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Residencies, Fellowships, and Postdoctoral Training |
|
|
Global Fund SR2020 |
Starley Shade, PhD, MPH |
Infectious Disease, Tuberculosis, Malaria |
|
|
Tuberculosis Risk Reduction Project |
George Rutherford, MD |
Tuberculosis, Implementation and Behavioral Science, Risk Reduction and Prevention |
|
|
Infectious disease laboratories |
George Rutherford, MD |
Infectious Disease, Tuberculosis |
|
|
Mozambique Tuberculosis Prevalence Survey (TGF 016-104) |
George Rutherford, MD |
HIV/AIDS, Tuberculosis |
|
|
Global Fund Prospective Country Evaluations |
George Rutherford, MD |
Infectious Disease, Tuberculosis, Malaria, Women's Health, Pediatrics |
|
|
Tuberculosis Risk Reduction Project |
George Rutherford, MD |
Tuberculosis, Systematic Reviews and Guideline Development, Epidemiology and Surveillance |
|
|
Mozambique Tuberculosis Prevalence Survey (TGF 016-104) |
George Rutherford, MD |
Tuberculosis, Epidemiology and Surveillance |
|
|
Tuberculosis Epidemiologic Studies Consortium |
George Rutherford, MD |
Tuberculosis |
|
|
Tuberculosis Epidemiologic Studies |
George Rutherford, MD |
Tuberculosis, Epidemiology and Surveillance |
|
|
BCP and HBAC Cost-Effectiveness Analysis |
George Rutherford, MD |
HIV/AIDS, Tuberculosis, Implementation and Behavioral Science, Engagement in Care, Treatment Adherence, Health Systems Strengthening, Training and Capacity Building, Patient and Peer Education |
|
|
Programmatic Implementation and Technical Assistance (TA) for HIV/AIDS and Tuberculosis (TB) Prevention, Care and Treatment Services throughout the Health System in South Africa |
George Rutherford, MD |
HIV/AIDS, Tuberculosis, Engagement in Care, Treatment Adherence |
|
|
Recent Infection Surveillance Consortium |
George Rutherford, MD |
HIV/AIDS, Tuberculosis |
|
|
Tuberculosis Free California |
George Rutherford, MD |
Tuberculosis |
|
|
Technical Assistance to CDC-Ukraine, Network ACCESS-Pro and the Ukrainian Public Health Center |
George Rutherford, MD |
HIV/AIDS, Infectious Disease, Transfusion Medicine, Tuberculosis, Health Systems Strengthening, Training and Capacity Building, Training International Scholars and Clinicians |
|
|
Implementation of The Global Fund's Programmatic Quality Assurance and Improvement Approach |
George Rutherford, MD |
HIV/AIDS, Tuberculosis, Malaria |
|
|
Tuberculosis Epidemiologic Studies Consortium |
George Rutherford, MD |
Tuberculosis |
|
|
Tuberculosis Epidemiologic Studies Consortium Project |
George Rutherford, MD |
Tuberculosis |
|
|
Tuberculosis Epidemiologic Studies Consortium |
George Rutherford, MD |
Tuberculosis, Epidemiology and Surveillance |
|
|
Doris Duke Charitable Foundation International Clinical Research Fellowship Program |
Joel Palefsky, MD |
HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Oral Health, Neurology and Mental Health, Women's Health, Pediatrics, Newborn and Infant Health, Immigration and Migration, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training |
|
|
TB Surrogate Markers for Assessing Response to Treatment (TB SMART Study) |
Payam Nahid, MD, MPH |
Tuberculosis |
|
|
TB Physician Services Contract |
Payam Nahid, MD, MPH |
Tuberculosis |
|
|
3HP for LTBI in Immigrants Pilot Study |
Payam Nahid, MD, MPH |
Tuberculosis |
|
|
Tuberculosis Trial Consortium |
Payam Nahid, MD, MPH |
Tuberculosis |
|
|
TB Surrogate Markers for Assessing Response to Treatment (TB SMART Study) |
Payam Nahid, MD, MPH |
Tuberculosis, Drug and Diagnostics Development |
|
|
Sputum Transcriptomic Expression Profiling in Study 31 (STEPS 31) |
Payam Nahid, MD, MPH |
Tuberculosis, Drug and Diagnostics Development |
|
|
Conduct a systematic review of interventions to improve adherence and retention during TB and HIV co-treatment among people living with HIV |
Payam Nahid, MD, MPH |
HIV/AIDS, Tuberculosis, Systematic Reviews and Guideline Development, Treatment Adherence |
|
|
Quantiferon+Pamp |
Payam Nahid, MD, MPH |
Tuberculosis |
|
|
TB Physician Services Contract |
Payam Nahid, MD, MPH |
Tuberculosis |
|
|
TB Physician Services |
Payam Nahid, MD, MPH |
Tuberculosis, Epidemiology and Surveillance, Implementation and Behavioral Science |
|
|
Leukopheresis Testing |
Payam Nahid, MD, MPH |
Tuberculosis |
|
|
Novel Maltodextrin-Based, Bacterial Targeting Probes for Bioimaging of Viable MTB In Vivo |
Payam Nahid, MD, MPH |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development |
|
|
Impact of the Number of Contacts on the Transmission of Tuberculosis - a Molecular Epidemiologic Study |
Payam Nahid, MD, MPH |
Tuberculosis, Epidemiology and Surveillance |
|
|
TB Physician Services |
Payam Nahid, MD, MPH |
Tuberculosis |
|
|
Evidence Reviews required for the revision of the WHO guidance on the treatment of TB. |
Payam Nahid, MD, MPH |
Tuberculosis, Policy and Standards of Care, Systematic Reviews and Guideline Development |
|
|
Interplay of Strain and Ethnicity in the Immune Response to M. tuberculosis |
Payam Nahid, MD, MPH |
Tuberculosis |
|
|
Novel Maltodextrin-Based, Bacterial Targeting Probes for Bioimaging of Viable MTB in Vivo |
Payam Nahid, MD, MPH |
Tuberculosis, Drug and Diagnostics Development |
|
|
TB Physician Services Contract |
Payam Nahid, MD, MPH |
Tuberculosis |
|
|
Tuberculosis Trials Consortium (TBTC) |
Payam Nahid, MD, MPH |
Tuberculosis, Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Real-Time Reagent-Free Noninvasive Diagnosis of Tuberculosis |
Payam Nahid, MD, MPH |
Tuberculosis |
|
|
TB Physician Services Contract |
Payam Nahid, MD, MPH |
Tuberculosis, Epidemiology and Surveillance, Implementation and Behavioral Science |
|
|
Sputum Transcriptomic Expression Profiling in Study 31: Express 31 |
Payam Nahid, MD, MPH |
HIV/AIDS, Tuberculosis |
|
|
Systematic Review Series: Non-commercial antibody detection for the dx of pulmonary TB |
Payam Nahid, MD, MPH |
Tuberculosis, Systematic Reviews and Guideline Development |
|
|
Development of an Integrated Social Franchising/ Health Co-op Model to Address TB and HIV among Poor in Sub-Saharan Africa |
Dominic Montagu, DrPH |
HIV/AIDS, Tuberculosis, Health Economics and Effectiveness |
|
|
Diagnostics, management, & transmission of MDR TB |
John Metcalfe, MD |
Tuberculosis |
|
|
Novel methods of pharmacologic monitoring for multidrug resistant tuberculosis treatment in the setting of HIV infection |
John Metcalfe, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis |
|
|
Improving Early Identification of Drug Resistant Tuberculosis in HIV Prevalent Settings |
John Metcalfe, MD |
HIV/AIDS, Tuberculosis |
|
|
Prevalence of baseline and longitudinal heteroresistant M. tuberculosis and association with patient-important outcomes |
John Metcalfe, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis |
|
|
Novel methods for monitoring long-term drug exposure and resistance amplification during treatment of multidrug resistant tuberculosis |
John Metcalfe, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development |
|
|
The impact of TB co-infection on the reservoir of persistent HIV in vivo |
Mike McCune, MD, PhD |
HIV/AIDS, Tuberculosis, Immunology |
|
|
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects |
Anne Luetkemeyer, MD |
HIV/AIDS, Tuberculosis |
|
|
Cepheid 077B-C: Evaluation of the Xpert® MTB/RIF Assay |
Anne Luetkemeyer, MD |
Tuberculosis |
|
|
Programmatic Implementation and Technical Assistance (TA) for HIV/AIDS and Tuberculosis (TB) Prevention, Care, and Treatment Services throughout the Health System in South Africa under the President's Emergency Plan |
Timothy Lane, PhD, MPH |
HIV/AIDS, Tuberculosis, Access or Barriers to Care, Stigma and Discrimination |
|
|
M tuberculosis Cells from Patients with Tuberculosis |
Midori Kato-Maeda, MD |
Tuberculosis |
|
|
Fitness Cost and Compensation in Quinolone-Resistant Mycobacterium tuberculosis |
Midori Kato-Maeda, MD |
Tuberculosis |
|
|
Improving the molecular diagnosis of drug resistant tuberculosis |
Midori Kato-Maeda, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Investigation of M. tuberculosis Cytochrome P450 Involvement in Cholesterol Utilization |
|
Tuberculosis |
|
|
AIDS Clinical Trials Network (ACTG) - Transformative Science Group Vice Chair) |
Peter Hunt, MD |
Infectious Disease, HIV/AIDS, Tuberculosis |
|
|
UCSF-FIND Uganda Project |
Laurence Huang, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
FIND Xpert MTB assay collaboration at Mulago Hospital |
Laurence Huang, MD |
Tuberculosis |
|
|
Transcriptional alterations in bronchoalveolar lavage fluid during treatment of human tuberculosis. |
Laurence Huang, MD |
Tuberculosis |
|
|
Patient-Oriented Research and Mentoring in HIV-associated Pulmonary Diseases |
Laurence Huang, MD |
HIV/AIDS, Tuberculosis, Noncommunicable and/or Chronic Disease |
|
|
Transcriptional alternations in bronchoalveolar lavage fluid during treatment of human tuberculosis |
Laurence Huang, MD |
HIV/AIDS, Tuberculosis |
|
|
Effect of Drug Resistance on Transmissibility and Pathogenicity of M. Tuberculosis |
Philip Hopewell, MD |
Tuberculosis |
|
|
TBRU: Tuberculosis Research Unit, Case Western Reserve University |
Philip Hopewell, MD |
Tuberculosis, Training and Capacity Building |
|
|
Task Order #22 Assessing the Integration of Social Network Analysis into Tuberculosis Contact Investigation Practice |
Philip Hopewell, MD |
Tuberculosis, Epidemiology and Surveillance |
|
|
Core Prevention and Control Project |
Philip Hopewell, MD |
Tuberculosis |
|
|
Master Agreement: Tuberculosis Epidemiologic Studies Consortium |
Philip Hopewell, MD |
Tuberculosis |
|
|
Targeted Testing and Treatment of Latent TB Infection |
Philip Hopewell, MD |
Tuberculosis |
|
|
Tuberculosis Training Scholarships (TBTS) |
Philip Hopewell, MD |
Tuberculosis, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training |
|
|
Technical Assistance: The National Tuberculosis and Leprosy Control Program: MDR/XDR TB Curry International Tuberculosis Center University of California, San Francisco |
Philip Hopewell, MD |
Tuberculosis |
|
|
Regional TB Training and Medical Consultation Center (RTMCC) |
Philip Hopewell, MD |
Tuberculosis, Training and Capacity Building |
|
|
TB TO 2015 |
Philip Hopewell, MD |
Tuberculosis |
|
|
Population-Based Molecular Epidemiology of Tuberculosis |
Philip Hopewell, MD |
Tuberculosis |
|
|
Tuberculosis Epidemiology and Novel Transmission Routes in Rural Tanzania |
Philip Hopewell, MD |
Tuberculosis, Epidemiology and Surveillance |
|
|
Evaluation of Smear Microscopy Methods |
Philip Hopewell, MD |
Tuberculosis, Policy and Standards of Care, Systematic Reviews and Guideline Development |
|
|
Systematic Review Series on "Antibody and Antigen Detection for the Immunodiagnosis of Tuberculosis" |
Philip Hopewell, MD |
Tuberculosis, Immunology, Systematic Reviews and Guideline Development |
|
|
Regional TB Training and Medical Consultation Center (RTMCC) |
Philip Hopewell, MD |
Tuberculosis, Training and Capacity Building |
|
|
Systematic Reviews of the Scientific Bases of Antituberculosis Chemotherapy ("Dogma" Review) |
Philip Hopewell, MD |
Tuberculosis, Systematic Reviews and Guideline Development |
|
|
Model Tuberculosis Education and Training Center |
Philip Hopewell, MD |
Tuberculosis, Training and Capacity Building |
|
|
HQHIV1003203 |
Philip Hopewell, MD |
HIV/AIDS, Tuberculosis |
|
|
Regional TB Training and Medical Consultation Center (RTMCC) |
Philip Hopewell, MD |
Tuberculosis, Training and Capacity Building |
|
|
Conducting Infection Control Assessment and Developing Educational Materials for Mexico |
Philip Hopewell, MD |
Tuberculosis |
|
|
Master Agreement: Tuberculosis Indefinite Quantity Contract (TB IQC) |
Philip Hopewell, MD |
Tuberculosis |
|
|
Population-Based Molecular Epidemiology of Tuberculosis in San Francisco |
Philip Hopewell, MD |
Tuberculosis, Epidemiology and Surveillance |
|
|
ATS Implementation Guide and Training Modules |
Philip Hopewell, MD |
Tuberculosis, Training and Capacity Building |
|
|
Coordination of the Development of Tuberculosis Contact Investigation Policy |
Philip Hopewell, MD |
Tuberculosis, Policy and Standards of Care |
|
|
Investigation of Indoor Solid Fuel and Kerosene Use as Tuberculosis Risk Factors |
Philip Hopewell, MD |
Tuberculosis |
|
|
Regional Capacity Building in Low Incidence Areas |
Philip Hopewell, MD |
Tuberculosis, Epidemiology and Surveillance, Engagement in Care |
|
|
Task Order Supplement to A5267 |
Diane Havlir, MD |
HIV/AIDS, Tuberculosis, Pharmacology and Drug Treatment |
|
|
SEARCH (Sustained East Africa Research in Community Health) Study in Kenya and Uganda/ Gates |
Diane Havlir, MD |
HIV/AIDS, Tuberculosis, Malaria, Cardiovascular Disease, Diabetes |
|
|
HIV/TB in Uganda: Punctuated Antiretroviral Therapy |
Diane Havlir, MD |
HIV/AIDS, Tuberculosis |
|
|
Simplified Isoniazid Preventive Therapy (SPIRIT) Strategy to Reduce TB Burden |
Diane Havlir, MD |
HIV/AIDS, Tuberculosis |
|
|
HIV/TB in Uganda: Punctuated Antiretroviral Therapy |
Diane Havlir, MD |
HIV/AIDS, Tuberculosis |
|
|
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects |
Diane Havlir, MD |
HIV/AIDS, Tuberculosis |
|
|
AIDS Clinical Trial Group (ACTG) Tuberculosis TSG Services |
Diane Havlir, MD |
HIV/AIDS, Tuberculosis |
|
|
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and Uninfected Pulmonary Tuberculosis Suspects |
Diane Havlir, MD |
HIV/AIDS, Tuberculosis |
|
|
AIDS Clinical Trial Research Group (ACTG), Studies: A5306, A5254, A5298 |
Diane Havlir, MD |
HIV/AIDS, Opportunistic Infection, Tuberculosis, Oral Health |
|
|
Interventions to reduce alcohol use and increase adherence to TB preventive therapy among HIV/TB co-infected drinkers (DIPT 1/2) |
Judith Hahn, PhD, MD |
HIV/AIDS, Tuberculosis, Substance Abuse, Treatment Adherence |
|
|
Training in Research Program on Alcohol Use by Persons with our at Risk for HIV |
Judith Hahn, PhD, MD |
HIV/AIDS, Tuberculosis, Substance Abuse, Residencies, Fellowships, and Postdoctoral Training |
|
|
URBAN ARCH (3/5) Uganda Cohort - TB preventive therapy for HIV-infected alcohol users in Uganda: an evaluation of safety, tolerability, and adherence, Hahn U01 Renewal |
Judith Hahn, PhD, MD |
HIV/AIDS, Tuberculosis, Substance Abuse |
|
|
Utility of Contact Investigation of Drug Susceptible and Resistant Tuberculosis in Tanzania |
Elizabeth Fair, PhD, MPH |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Epidemiology and Surveillance |
|
|
Compilation, Synthesis and Grading of Evidence for Questions 5 and 6 |
Elizabeth Fair, PhD, MPH |
Tuberculosis, Systematic Reviews and Guideline Development |
|
|
REAC AWARD-Using mobile technologies and community health workers to find and support TB contacts in Beira, Mozambique |
Elizabeth Fair, PhD, MPH |
Tuberculosis, Epidemiology and Surveillance |
|
|
Capacity Building for Management of First Line Drug Resistant TB in Tanzania |
Elizabeth Fair, PhD, MPH |
Tuberculosis, Training and Capacity Building |
|
|
Effectiveness of QuantiFERON-TB Gold (QFT-G) in Contact Tracing |
Elizabeth Fair, PhD, MPH |
Tuberculosis, Drug and Diagnostics Development |
|
|
Evaluation of interferon Gamma Release Assays in Overseas Immigration Examination of Children in Moderate and high Burden Countries |
Elizabeth Fair, PhD, MPH |
Tuberculosis, Pediatrics |
|
|
Core Requirements: Tuberculosis Epidemiologic Studies Consortium |
Elizabeth Fair, PhD, MPH |
Tuberculosis |
|
|
Tuberculosis contact tracing in resource poor settings |
Elizabeth Fair, PhD, MPH |
Tuberculosis, Epidemiology and Surveillance |
|
|
Sputum M. tuberculosis DNA Kinetics during TB Treatment in Patients with HIV |
|
HIV/AIDS, Tuberculosis |
|
|
CORE B: Intracellular Pathogens and Innate Immunity |
Joseph Derisi, PhD |
Tuberculosis, Immunology |
|
|
Clinical and Public Health Impact of Automated Nucleic Acid Testing (Cepheid GeneXpert) to Rule-out Tuberculosis in San Francisco |
|
Tuberculosis |
|
|
Mobile Health for Implementation of Home-based TB Contact Investigation in Uganda |
|
Tuberculosis, Implementation and Behavioral Science |
|
|
Sputum Processing Methods |
|
Tuberculosis, Drug and Diagnostics Development |
|
|
Accelerating and Intensifying Tuberculosis Case Finding in Uganda |
|
Tuberculosis, Residencies, Fellowships, and Postdoctoral Training |
|
|
Frontloaded Sputum Microscopy |
|
Tuberculosis |
|
|
A Novel Proteomic Approach to Tuberculosis Biomarker Discovery using Human Exosomes |
|
Tuberculosis |
|
|
UCB-UCSF-MU Research Training on Tuberculosis (TB) and Other Pulmonary Complications of HIV |
|
HIV/AIDS, Opportunistic Infection, Tuberculosis, Chronic Respiratory Disease, Health Systems Strengthening, Training and Capacity Building, Training International Scholars and Clinicians |
|
|
Exosomes as Biomarkers for Tuberculosis |
|
Tuberculosis |
|
|
Oral Wash for Nucleic Acid Diagnosis and Prognosis of TB in HIV-infected Ugandans |
|
HIV/AIDS, Tuberculosis, Drug and Diagnostics Development |
|
|
Secretion of Virulence Factors by Mycobacterium tuberculosis |
|
Infectious Disease, HIV/AIDS, Tuberculosis, Genetics |
|
|
Uncovering How Mycobacterium Tuberculosis Utilizes a Novel Protein Secretion System to Manipulate Host Response During Infection |
|
Tuberculosis |
|
|
Structural Genomics of Persistence Targets from M. Tuberculosis |
|
Tuberculosis |
|
|
Host-Directed Strategies to Create Synergistic Antibacterial Therapies |
|
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development, Immunology |
|
|
Role of MmpL Transporters in M. Tuberculosis Virulence |
|
Tuberculosis |
|
|
Targeting host autophagy for treating Mtb infections and synergizing with antibiotics in vivo |
|
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Pharmacology and Drug Treatment |
|
|
Manipulation of Macrophage Responses by M. tuberculosis |
|
Tuberculosis |
|
|
Determination of the M. tuberculosis proteome interaction map (iMAP) during persistence |
|
Tuberculosis |
|
|
Regulation of ESX-1 secretion and its role in M. tuberculosis virulence |
|
Tuberculosis |
|
|
Discovery of novel, ubiquitin-regulated mechanisms of TB control by macrophages |
|
Tuberculosis, Immunology |
|
|
Manipulation of Macrophage Responses by M. tuberculosis |
|
Tuberculosis |
|
|
Regulation of ESX-1 Secretion and Its Role in Mycobacterium tuberculosis Virulence |
|
Tuberculosis |
|
|
Manipulation of Macrophage Responses by M. Tuberculosis |
|
Tuberculosis |
|
|
University of California Global Health Institute Program for Fellows and Scholars |
Craig Cohen, MD, MPH |
Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Malaria, Noncommunicable and/or Chronic Disease, Surgery and Anesthesia, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity, Eye Disease and Blindness, Oral Health, Drug and Diagnostics Development, Immunology, Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Aging, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Effectiveness, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination, Smoking and Tobacco, Policy and Standards of Care, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Triangulation, Global Strategic Information, Implementation and Behavioral Science, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training |
|
|
East Africa IEDEA Regional Consortium |
Craig Cohen, MD, MPH |
HIV/AIDS, Tuberculosis, Cancer/Oncology, Epidemiology and Surveillance |
|
|
University of California Global Health Institute Program for Fellows and Scholars |
Craig Cohen, MD, MPH |
Infectious Disease, HIV/AIDS, Tuberculosis, Malaria, Surgery and Anesthesia, Cancer/Oncology, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Pediatrics, Policy and Standards of Care, Epidemiology and Surveillance |
|
|
Family-Based HIV Voluntary Testing and Counseling in Patients at Risk for Tuberculosis |
Edwin Charlebois, PhD |
HIV/AIDS, Tuberculosis, Implementation and Behavioral Science |
|
|
Molecular Epidemiology and Geospatial Analysis of Tuberculosis Transmission in Uganda |
Gabriel Chamie, MD |
HIV/AIDS, Tuberculosis, Epidemiology and Surveillance |
|
|
Mobile Phone Platform for Genomic Disease Detection |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development, Genetics |
|
|
Evaluation of the performance of rapid, non-sputum based, biomarker-based test for tuberculosis (TB) diagnosis |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
1180: From DOT to DAT: An evaluation of 99DOTS to improve tuberculosis treatment adherence in Uganda |
Adithya Cattamanchi, MD |
Tuberculosis, Treatment Adherence |
|
|
Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options Trial |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development, Health Economics and Effectiveness |
|
|
SIngle-saMPLE tuberculosis evaluation to facilitate linkage to care: The SIMPLE TB trial |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Mobile Health for Implementation of Home-based TB Contact Investigation in Uganda |
Adithya Cattamanchi, MD |
Tuberculosis, Epidemiology and Surveillance |
|
|
Streamlined TB Diagnosis |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
TB Guideline Observation and Adherence in Low Income Countries (TB GOAL) |
Adithya Cattamanchi, MD |
Tuberculosis, Systematic Reviews and Guideline Development |
|
|
Comparative Effectiveness of Rapid Diagnostics for Tuberculosis in Uganda |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development, Epidemiology and Surveillance |
|
|
Novel Technologies to Increase the Accessibility and Accuracy of Tuberculosis Diagnostic Services in Hanoi Province, Vietnam |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
A User-Friendly Epidemic-Economic Model of Diagnostic Tests for Tuberculosis |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development, Epidemiology and Surveillance |
|
|
Modeling the Reproducibility of Blood Assays for TB Infection |
Adithya Cattamanchi, MD |
Tuberculosis |
|
|
Automated smear-positive tuberculosis diagnosis |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
TB Diagnosis Technology |
Adithya Cattamanchi, MD |
Tuberculosis |
|
|
Human-centered Design and Communities of Practice to Improve Delivery of Home-based Tuberculosis Contact Investigation in Uganda |
Adithya Cattamanchi, MD |
HIV/AIDS, Tuberculosis, Engagement in Care |
|
|
To carry out re-analysis of data from 5 studies on use Loop-mediated Isothermal Amplication (TB-Lamp) technology for rapid TB diagnostics, stratification of results and reporting |
Adithya Cattamanchi, MD |
Tuberculosis, Systematic Reviews and Guideline Development |
|
|
Immunodiagnosis of Active Tuberculosis in HIV-Infected Patients |
Adithya Cattamanchi, MD |
HIV/AIDS, Tuberculosis, Drug and Diagnostics Development |
|
|
Interferon-Gamma Release Assays for the Diagnosis of Tuberculosis in Adults |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
LOC-IMPAACT Leadership Group |
Francesca Aweeka, PharmD |
HIV/AIDS, Tuberculosis, Drug and Diagnostics Development, Pharmacology and Drug Treatment, Women's Health, Pediatrics, Newborn and Infant Health, Systematic Reviews and Guideline Development |
|
|
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) |
Francesca Aweeka, PharmD |
HIV/AIDS, Tuberculosis, Malaria, Women's Health, Pediatrics, Adolescent Health |
|
|
2.1 Project Title ACTG: AIDS Clinical Trials Group |
Francesca Aweeka, PharmD |
Infectious Disease, HIV/AIDS, Tuberculosis |
|
|